Calumet Total Assets from 2010 to 2024

CLMT Stock

USD 22.40 0.24 1.08%

Calumet Specialty Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 1.8 B in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2003-12-31

Previous Quarter

2.7 B

Current Value

2.6 B

Quarterly Volatility

916.3 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Calumet Specialty financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Calumet Specialty's main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.3 M, Interest Expense of 232.8 M or Selling General Administrative of 154 M, as well as many indicators such as Price To Sales Ratio of 0.26, Dividend Yield of 0.096 or Days Sales Outstanding of 26.35. Calumet financial statements analysis is a perfect complement when working with Calumet Specialty Valuation or Volatility modules.

Check out the analysis of Calumet Specialty Correlation against competitors.

Latest Calumet Specialty's Total Assets Growth Pattern

Below is the plot of the Total Assets of Calumet Specialty Products over the last few years. Total assets refers to the total amount of Calumet Specialty assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Calumet Specialty books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Calumet Specialty's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Calumet Specialty's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 2.75 B

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Total Assets

Timeline

Calumet Total Assets Regression Statistics

	Arithmetic Mean	2,231,802,497
	Geometric Mean	1,962,514,483
	Coefficient Of Variation	32.86
	Mean Deviation	541,110,003
	Median	2,253,045,000
	Standard Deviation	733,265,474
	Sample Variance	537678.3T
	Range	2.9B
	R-Value	0.23
	Mean Square Error	547106.9T
	R-Squared	0.06
	Significance	0.40
	Slope	38,503,515
	Total Sum of Squares	7527495.6T

Calumet Total Assets History

	2024	1.8 B
	2023	2.8 B
	2022	2.7 B
	2021	2.1 B
	2020	1.8 B
	2019	1.9 B
	2018	2.1 B

Other Fundumenentals of Calumet Specialty

Intangibles To Total Assets

Calumet Specialty Total Assets component correlations

	Total Assets	Total Stockholder Equity	Total Liab	Accounts Payable	Long Term Debt	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Net Debt	Net Receivables	Total Current Assets	Short Term Debt	Good Will	Net Tangible Assets	Short Term Investments	Long Term Debt Total	Deferred Long Term Liab	Common Stock	Short Long Term Debt	Net Invested Capital	Net Working Capital
Total Assets		0.24	0.81	0.85	0.83	0.64	0.93	0.23	0.8	0.84	0.74	0.21	0.82	-0.23	-0.08	0.71	0.12	0.29	0.2	0.09	-0.05
Total Stockholder Equity	0.24		-0.3	0.33	-0.18	0.75	0.02	-0.49	-0.27	0.18	0.32	-0.49	0.12	0.8	-0.84	-0.34	-0.76	0.91	-0.17	0.75	0.74
Total Liab	0.81	-0.3		0.62	0.92	0.18	0.86	0.5	0.95	0.68	0.49	0.57	0.69	-0.7	0.38	0.85	0.45	-0.24	0.28	-0.35	-0.45
Accounts Payable	0.85	0.33	0.62		0.51	0.48	0.74	0.35	0.5	0.77	0.72	0.2	0.58	-0.08	-0.16	0.37	0.21	0.23	0.02	0.01	-0.21
Long Term Debt	0.83	-0.18	0.92	0.51		0.38	0.9	0.28	0.98	0.65	0.42	0.31	0.76	-0.59	0.22	0.95	0.26	-0.05	0.22	-0.15	-0.18
Intangible Assets	0.64	0.75	0.18	0.48	0.38		0.48	-0.33	0.29	0.45	0.41	-0.35	0.66	0.39	-0.67	0.3	-0.5	0.88	-0.06	0.6	0.57
Property Plant Equipment	0.93	0.02	0.86	0.74	0.9	0.48		0.31	0.88	0.66	0.49	0.18	0.74	-0.38	-0.01	0.82	0.25	0.07	0.06	-0.03	-0.19
Current Deferred Revenue	0.23	-0.49	0.5	0.35	0.28	-0.33	0.31		0.38	0.34	0.14	0.56	0.22	-0.68	0.53	0.33	0.78	-0.58	0.08	-0.67	-0.79
Net Debt	0.8	-0.27	0.95	0.5	0.98	0.29	0.88	0.38		0.66	0.42	0.43	0.72	-0.65	0.29	0.95	0.33	-0.15	0.31	-0.2	-0.26
Net Receivables	0.84	0.18	0.68	0.77	0.65	0.45	0.66	0.34	0.66		0.89	0.35	0.64	-0.2	0.06	0.56	0.19	0.19	0.51	0.11	-0.05
Total Current Assets	0.74	0.32	0.49	0.72	0.42	0.41	0.49	0.14	0.42	0.89		0.33	0.47	0.0	0.0	0.3	0.03	0.3	0.58	0.23	0.07
Short Term Debt	0.21	-0.49	0.57	0.2	0.31	-0.35	0.18	0.56	0.43	0.35	0.33		0.11	-0.63	0.62	0.3	0.43	-0.53	0.64	-0.47	-0.56
Good Will	0.82	0.12	0.69	0.58	0.76	0.66	0.74	0.22	0.72	0.64	0.47	0.11		-0.34	0.05	0.72	0.2	0.33	0.04	-0.11	-0.12
Net Tangible Assets	-0.23	0.8	-0.7	-0.08	-0.59	0.39	-0.38	-0.68	-0.65	-0.2	0.0	-0.63	-0.34		-0.84	-0.65	-0.73	0.73	-0.19	0.82	0.76
Short Term Investments	-0.08	-0.84	0.38	-0.16	0.22	-0.67	-0.01	0.53	0.29	0.06	0.0	0.62	0.05	-0.84		0.28	0.73	-0.79	0.32	-0.83	-0.73
Long Term Debt Total	0.71	-0.34	0.85	0.37	0.95	0.3	0.82	0.33	0.95	0.56	0.3	0.3	0.72	-0.65	0.28		0.38	-0.16	0.24	-0.21	-0.25
Deferred Long Term Liab	0.12	-0.76	0.45	0.21	0.26	-0.5	0.25	0.78	0.33	0.19	0.03	0.43	0.2	-0.73	0.73	0.38		-0.73	0.0	-0.79	-0.92
Common Stock	0.29	0.91	-0.24	0.23	-0.05	0.88	0.07	-0.58	-0.15	0.19	0.3	-0.53	0.33	0.73	-0.79	-0.16	-0.73		-0.11	0.76	0.77
Short Long Term Debt	0.2	-0.17	0.28	0.02	0.22	-0.06	0.06	0.08	0.31	0.51	0.58	0.64	0.04	-0.19	0.32	0.24	0.0	-0.11		0.15	0.08
Net Invested Capital	0.09	0.75	-0.35	0.01	-0.15	0.6	-0.03	-0.67	-0.2	0.11	0.23	-0.47	-0.11	0.82	-0.83	-0.21	-0.79	0.76	0.15		0.9
Net Working Capital	-0.05	0.74	-0.45	-0.21	-0.18	0.57	-0.19	-0.79	-0.26	-0.05	0.07	-0.56	-0.12	0.76	-0.73	-0.25	-0.92	0.77	0.08	0.9

Click cells to compare fundamentals

About Calumet Specialty Financial Statements

Calumet Specialty shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Calumet Specialty investors may analyze each financial statement separately, they are all interrelated. The changes in Calumet Specialty's assets and liabilities, for example, are also reflected in the revenues and expenses on on Calumet Specialty's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	2.8 B	1.8 B
Intangibles To Total Assets	0.07	0.09

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Calumet Stock Analysis

When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC